mdxhealth
Sathish Kumar Ganesan, PhD, is currently a Product Development Scientist at mdxhealth since August 2023. Prior experience includes a Postdoctoral Resource Employee role at the University of Southern California, where research focused on cell-based assays and the role of androgen receptor in estrogen receptor-positive breast cancer. Dr. Ganesan completed a PhD in Cancer Biology and Genomics at the University of Southern California, following a Master's in Molecular Microbiology and Immunology from the Keck School of Medicine of the University of Southern California. Early career positions included various roles in translational research at Astellas Pharma US and research positions at USC Norris Comprehensive Cancer Center and ADHICHUNCHANAGIRI Biotech and Cancer Research Institute. Educational background also includes a B.Tech in Industrial Biotechnology from Anna University Chennai.
This person is not in any offices
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.